MR

Michael Retchin

Founder of NewCo

San Francisco, California

Overview 

Michael Retchin is a highly accomplished individual with a background in bioinformatics and molecular biology, having held significant roles at prestigious institutions like Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology. Currently, he serves as the Founder of NewCo, leveraging his expertise in entrepreneurship and scientific intelligence to invest in sectors such as Pharmaceuticals and BioTech, particularly focusing on female and diverse founders in regions like New York City and San Francisco Bay Area.

Work Experience 

  • Founder

    2024 - Current

    Building scientific intelligence.

  • Co-President

    2023 - 2024

    World's largest biotech accelerator.

  • Founding EVP

    2020 - 2023

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

  • Researcher, Chodera Lab

    2020 - 2024

    ML for drug discovery.

  • Senior Associate

    2020 - 2023

    Biotech investing.

Pillar VC invests in seed-stage companies, supporting unstoppable founders with capital, connections, coaching, and peer support.

  • Machine Learning

    2020 - 2020

    ML for proteins.

  • Machine Learning

    2017 - 2020

    A venture studio best known for founding Moderna. ProFound Therapeutics (2020) Cellarity (2017-2019)

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Researcher, Shalek Lab

    2019 - 2020

    ML for organoids.

  • Founding Team

    2017 - 2019

    Led ML from inception through Series A.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Raised $294,000,000.00 from Kyowa Kirin, Flagship Pioneering and Hanwha Impact Partners.

  • Researcher, Sarkar Lab

    2014 - 2015

    ML for RNA.

Articles About Michael

Relevant Websites